Ability to downregulate the level of cyclin-dependent kinase inhibitor p27(Kip1) after DNA damage is retained in chronic lymphocytic leukemia cells with functional ATM/p53 signaling pathway

LEUKEMIA & LYMPHOMA

Kafkova, LR; Navrkalova, V; Jarosova, M; Loja, T; Chovancova, J; Kucerova, J; Kriegova, E; Prochazka, V; Novak, Z; Simkova, D; Pospisilova, S; Divoky, V, 2017: Ability to downregulate the level of cyclin-dependent kinase inhibitor p27(Kip1) after DNA damage is retained in chronic lymphocytic leukemia cells with functional ATM/p53 signaling pathway. LEUKEMIA & LYMPHOMA 58(1), p. 199 - 203, doi: 10.1080/10428194.2016.1187276

Research Groups:

• Medical Genomics - Šárka Pospíšilová
• Behavioural and Social Neuroscience - Milan Brázdil
• Molecular Oncology - Solid Cancer - Ondřej Slabý

CEITEC authors:

• Tomáš Loja, Ph.D.
• Prof. Šárka Pospíšilová, Ph.D.
• Veronika Navrkalová, Ph.D.